Boston Scientific Scimed, Inc.

Lifespan Corporation

Kathleen Corcoran

John Allen Hingston

Gene Thomas Storbeck

Jeri Ann Hiller

Kali L Manning

Gary Dean Roye

Sivamainthan Vithiananthan

Beth Ryder

Selina M Mello

Martyn G Folan

Holly Elizabeth Rockweiler

Thomas M Keating

Kevin Walsh

Ding Sheng He

Damien Vincent Nolan

Martin Hynes

Daniel Lee Krautkremer

Allison M Pearlman

Selina Merkling

Bryan Forde

Peter J Snyder

Kevin M Reavis

Dawn Winsor-Hines

Harlan Rich

Jill M White

A device for implanting in a gastrointestinal system of a patient may include an elongate flow modulator configured to be inserted in an intestine, wherein the flow modulator defines an enclosed interior space to hold a fill material.

Devices and methods for modulating intestinal flow

A delivery system for delivering an implant having both a rigid portion and a flexible portion to a body lumen. The delivery system includes an outer tubular member and an inner tubular member slidably disposed within the lumen of the outer tubular member. The inner tubular member includes at least one opening positioned in a side wall adjacent to a distal end region. An expandable implant, including a rigid portion and a flexible portion, is disposed about the outer surface of the inner tubular member. A distal portion of a thread is wrapped around the flexible portion of the implant and configured to maintain the flexible portion in a radially collapsed configuration during delivery of the implant. A distal end region of the outer tubular member is disposed around the rigid portion of the implant to maintain the rigid portion in a radially collapsed configuration during delivery of the implant.

Stent and sleeve deployment

A system for treating a gastrointestinal tract may include a device configured to measure electrical activity at a plurality of locations within a gastrointestinal tract of a patient, a controller configured to compare the measured activity from the plurality of locations to a database of electrical activity corresponding to one or more gastric events, abnormalities, or dysrhythmias. The controller may be configured to determine one or more treatment locations based on the comparison, and cause the device to deliver therapy to the one or more treatment locations.

Systems and methods for obesity diagnosis and/or treatment

A reduced absorption device may include a proximal anchor and a distal sleeve including a frame and a membrane. The membrane may include a plurality of porous regions, and each porous region may be configured to align with a corresponding region of an intestine configured to absorb nutrients.

Devices and methods for reducing absorption

A stent includes a tubular support structure extending from a distal end to a proximal end, the tubular support structure including an inner surface and an outer surface. A retractable anchor system is disposed relative to the tubular support structure and includes a frame member and a plurality of retractable anchors secured to the frame member. The plurality of retractable anchors are biased to a deployed configuration in which the plurality of retractable anchors extend radially outward from the outer surface of the tubular support structure but are radially inwardly compressible into a delivery configuration.

Stent with retractable anchors

Growing community of inventors

Watertown, MA, United States of America

Kathleen Corcoran